NYSEAMERICAN:TRXCTransEnterix Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding TransEnterix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.44 -0.02 (-3.82 %) (As of 08/7/2020 04:00 PM ET) Add Compare Share Today's Range$0.42Now: $0.44▼$0.4550-Day Range N/A52-Week Range$0.28Now: $0.44▼$14.43Volume2.17 million shsAverage Volume3.74 million shsMarket Capitalization$22.81 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.Read More Beat the Market (BTM) Rank™ 3.0 Analyst's Opinion Consensus RatingTransEnterix has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $1.00, TransEnterix has a potential upside of 127.2% from its current price of $0.44.Amount of Analyst CoverageTransEnterix has received no research coverage in the past 90 days. Previous Next 2.3 Community Rank Outperform VotesTransEnterix has received 451 “outperform” votes. (Add your “outperform” vote.)Underperform VotesTransEnterix has received 513 “underperform” votes. (Add your “underperform” vote.)Community SentimentTransEnterix has received 53.22% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about TransEnterix and other stocks. Vote “Outperform” if you believe TRXC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TRXC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldTransEnterix does not currently pay a dividend.Dividend GrowthTransEnterix does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, TransEnterix insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.06 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:TRXC Previous Symbol CUSIPN/A CIK876378 Webwww.transenterix.com Phone+1-919-7658400Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares51,839,000Market Cap$22.81 million Next Earnings Date11/10/2020 (Estimated) OptionableOptionable $0.44 -0.02 (-3.82 %) (As of 08/7/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive TRXC News and Ratings via Email Sign-up to receive the latest news and ratings for TRXC and its competitors with MarketBeat's FREE daily newsletter. TransEnterix (NYSEAMERICAN:TRXC) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of TransEnterix? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TransEnterix in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for TransEnterix. When is TransEnterix's next earnings date? TransEnterix is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020. View our earnings forecast for TransEnterix. How were TransEnterix's earnings last quarter? TransEnterix, Inc. (NYSEAMERICAN:TRXC) posted its quarterly earnings data on Wednesday, August, 5th. The medical instruments supplier reported ($0.21) EPS for the quarter, topping the consensus estimate of ($0.38) by $0.17. View TransEnterix's earnings history. What price target have analysts set for TRXC? 1 Wall Street analysts have issued 12-month price targets for TransEnterix's stock. Their forecasts range from $1.00 to $1.00. On average, they anticipate TransEnterix's share price to reach $1.00 in the next twelve months. This suggests a possible upside of 127.2% from the stock's current price. View analysts' price targets for TransEnterix. Has TransEnterix been receiving favorable news coverage? News stories about TRXC stock have been trending very positive recently, according to InfoTrie Sentiment. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. TransEnterix earned a daily sentiment score of 4.0 on InfoTrie's scale. They also gave media coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about TransEnterix. Are investors shorting TransEnterix? TransEnterix saw a decrease in short interest in July. As of July 31st, there was short interest totaling 2,510,000 shares, a decrease of 14.6% from the July 15th total of 2,940,000 shares. Based on an average daily trading volume, of 4,760,000 shares, the short-interest ratio is currently 0.5 days. Approximately 2.7% of the company's stock are short sold. View TransEnterix's Current Options Chain. Who are some of TransEnterix's key competitors? Some companies that are related to TransEnterix include Daxor (DXR), Daxor (DXR), IsoRay (ISR), IsoRay (ISR), TSO3 (TOS), Impression Healthcare (IHL), G Medical (GMV), Akers Biosciences (AKR), Relevium Technologies (RLV), Vigil Health Solutions (VGL), Ambu A/S (AMBBY), Ansell (ANSLF), ANSELL LTD/S (ANSLY), Commerzbank (CZMWY) and CONVATEC GRP PL/ADR (CNVVY). View all competitors. What other stocks do shareholders of TransEnterix own? Based on aggregate information from My MarketBeat watchlists, some companies that other TransEnterix investors own include Oramed Pharmaceuticals (ORMP), Compugen (CGEN), Editas Medicine (EDIT), Ekso Bionics (EKSO), XOMA (XOMA), Actinium Pharmaceuticals (ATNM), Geron (GERN), NVIDIA (NVDA), Advanced Micro Devices (AMD) and Opko Health (OPK). Who are TransEnterix's key executives? TransEnterix's management team includes the following people: Mr. Todd M. Pope, CEO, Pres & Director (Age 53)Mr. Joseph P. Slattery, Exec. VP, CFO & Principal Accounting Officer (Age 53)Mr. Anthony Fernando, COO, CTO & Exec. VP (Age 46)Mr. Joshua B. Weingard, Chief Legal Officer & Sec. (Age 45)Dr. Stephanie M. Fitts Ph.D., VP of RA/QA, Clinical and Compliance (Age 52) What is TransEnterix's stock symbol? TransEnterix trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "TRXC." How do I buy shares of TransEnterix? Shares of TRXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is TransEnterix's stock price today? One share of TRXC stock can currently be purchased for approximately $0.44. How big of a company is TransEnterix? TransEnterix has a market capitalization of $22.81 million. What is TransEnterix's official website? The official website for TransEnterix is www.transenterix.com. How can I contact TransEnterix? TransEnterix's mailing address is 635 Davis Dr Ste 300, MORRISVILLE, NC 27560-7199, United States. The medical instruments supplier can be reached via phone at +1-919-7658400. This page was last updated on 8/8/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
